Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Natl Med Assoc ; 110(3): 276-280, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29778131

RESUMEN

BACKGROUND: Ulcerative colitis (UC) is a chronic, inflammatory bowel diseases characterized by uncontrolled inflammatory condition of the colon and rectal mucosa marked by recurrent periods of remission and exacerbation. Vitamin D receptor (VDR) is a member of the steroid receptor family that mediates the effects of vitamin D by regulating transcription of multiple cellular genes. We aimed to evaluate vitamin d receptor level in biopsy specimen of patients with UC in this study. METHODS: VDR levels were retrospectively studied in colon biopsy specimens of UC patients. The Spearman's rho correlation analysis, The Kolmogorov-Smirnov, Mann Whitney U, and chi-square tests were used for statistical analysis. The p values below 0.05 were considered statistically significant. RESULTS: Study included 112 UC patients (65 male and 47 female) and 30 controls (19 female and 11 male) who had normal results in biopsy examinations carried out due to various reasons. VDR levels of UC patients were statistically lower than control subjects, and was not associated with duration of the disease and place of involvement. CONCLUSIONS: VDR is an important receptor in the pathogenesis of UC, and optimizing vitamin D levels could have a therapeutic role in UC.


Asunto(s)
Colitis Ulcerosa , Colon , Receptores de Calcitriol/metabolismo , Recto , Adulto , Biopsia/métodos , Colitis Ulcerosa/metabolismo , Colitis Ulcerosa/patología , Colon/metabolismo , Colon/patología , Correlación de Datos , Femenino , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Recto/metabolismo , Recto/patología , Reproducibilidad de los Resultados , Turquía
2.
Gastroenterol Rep (Oxf) ; 6(3): 228-230, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-27576471

RESUMEN

Drug-induced liver damage is a frequently encountered clinical table caused by many drugs. Cetirizine is a widely preferred and prescribed antihistaminic agent for allergic disorders due to its non-sedative properties. In view of the literature, we present four cases of hepatotoxicity due to cetirizine use. We conclude that in patients with high levels of liver enzymes of unknown origin, cetirizine as well as other hepatotoxic drugs should be reconsidered.

3.
J Pak Med Assoc ; 65(12): 1305-9, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26627512

RESUMEN

OBJECTIVE: To investigate the relationship between dyspepsia symptom scores and endoscopic appearances, and histopathological findings and helicobacter pylori positivity in patients having dyspepsia symptom. METHODS: The study was conducted at the gastroenterology outpatient clinic of Adnan Menderes University, School of Medicine, Aydin, Turkey from April 2012 to July 2012 and comprised patients between 18-65 years of age who were admitted with dyspepsia. Glasgow dyspepsia severity scoring was done with questions posed orally to the patients. In histopathological evaluation of biopsy specimens according to Sydney criteria, chronic inflammation, activity, atrophy, intestinal metaplasia and helicobacter pylori parameters were used. Total number of eosinophils and number of mast cells were recorded. RESULTS: Of the 60 patients with dyspepsia, 38(63.3%) were female and 22(36.7%) were male. The degree of activation and severity of inflammation increased significantly with increasing helicobacter pylori positivity(r=0.459'p<0.0001; r=0.475'p<0.0001). A significant relationship was found between inflammation, activation and the number of mast cells (p<0.05).There was no relationship between helicobacter pylori intensity and the eosinophil count (r=0.171; p=0.093). There was also a statistically significant correlation between severity of inflammation and activation and the number of eosinophils (r=0.313;p=0.002;r=0.245;p=0.016). CONCLUSIONS: Mast cell density was seen to have a role in the inflammatory processes of helicobacter pylori infection.


Asunto(s)
Dispepsia/microbiología , Dispepsia/patología , Endoscopía Gastrointestinal , Infecciones por Helicobacter/complicaciones , Helicobacter pylori , Adolescente , Adulto , Anciano , Estudios de Cohortes , Femenino , Infecciones por Helicobacter/patología , Humanos , Masculino , Persona de Mediana Edad , Turquía , Adulto Joven
4.
Euroasian J Hepatogastroenterol ; 4(2): 98-100, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-29699356

RESUMEN

Esophageal leiomyoma is the most common benign intramural tumor of esophagus. Although its incidence is not exactly known, it is very rare (0.006%-0.1% in autopsy series). It is generally asymptomatic and detected incidentally. Here, we present a rare case report describing coexistence of megaloblastic anemia and esophageal leiomyoma. How to cite this article: Coskun A, Unubol M, Yukselen O, Yukselen V, Aydin A, Sen S, Karaoglu AO. Esophageal Leiomyoma in Patients with Megaloblastic Anemia. Euroasian J Hepato-Gastroenterol 2014;4(2):98-100.

5.
Intern Med ; 52(23): 2615-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24292750

RESUMEN

A 43-year-old woman was first admitted to the ophthalmology clinic with the complaint of a mass compressing the right eye. Based on clinical and laboratory examinations she was diagnosed as having marginal zone lymphoma (MZL) of the right lacrimal gland in addition to hepatitis C virus (HCV) infection. After the treatment for HCV infection with pegylated interferon plus ribavirin, a radiographic response of the MZL was obtained; she remains in remission through thirty months of clinical follow-up. In this case, the treatment of HCV infection led to regression of MZL suggesting the necessity of testing for HCV infection and treatment of the HCV infection should be highly considered in all HCV-positive patients with MZL's.


Asunto(s)
Antivirales/uso terapéutico , Neoplasias del Ojo/complicaciones , Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/tratamiento farmacológico , Aparato Lagrimal , Linfoma de Células B de la Zona Marginal/complicaciones , Adulto , Neoplasias del Ojo/diagnóstico por imagen , Neoplasias del Ojo/patología , Femenino , Humanos , Interferón alfa-2 , Interferón-alfa/uso terapéutico , Aparato Lagrimal/diagnóstico por imagen , Linfoma de Células B de la Zona Marginal/diagnóstico por imagen , Linfoma de Células B de la Zona Marginal/patología , Polietilenglicoles/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Inducción de Remisión , Ribavirina/uso terapéutico , Tomografía Computarizada por Rayos X
6.
Transfus Apher Sci ; 47(1): 61-5, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22583545

RESUMEN

Therapeutic apheresis (TA) is used as primary and adjunctive therapy in the treatment of several diseases and syndromes. We retrospectively evaluated the results of therapeutic apheresis (TA) including therapeutic plasma-exchange (TPE), double filtration plasmapheresis (DFPP), therapeutic thrombocytapheresis and leukocytapheresis as 11-year activity during 2000-2011. A total of 845 TA procedures were performed in 114 patients (67 male and 47 female, with mean age 51±17 years). Adverse events (AE) were seen in 8.6% of procedures. None of the patients died from any complication. TA is safely carried out in our center in several diseases which are similar to previous reports.


Asunto(s)
Eliminación de Componentes Sanguíneos , Sistema de Registros , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Turquía
7.
Transfus Apher Sci ; 43(3): 285-289, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20926345

RESUMEN

Hypertriglyceridemia causes acute pancreatitis in 1.3-3.8% of patients. We report here on two cases with severe (triglyceride level >1000 mg/dL) hypertriglyceridemia-induced acute recurrent pancreatitis. Both patients had uncontrolled hypertriglyceridemia and suffered from acute pancreatitis. No cause of secondary hypertriglyceridemia was detected. While stage E pancreatitis (Ranson's score: 2) was diagnosed in the first case, stage D pancreatitis with a null Ranson's score was detected in the second case. Both patients were treated with classical treatment with fluid replacement, analgesic, antibiotics and discontinuation of oral intake. Therapeutic plasma exchange (TPE) with fresh frozen plasma was performed consecutively and with two procedures on the 2nd and 3rd day in the first case. After TPE, while the triglyceride levels decreased from 4408 to 302 mg/dL, the amylase levels dropped from 4234 to 171 IU/L. In the second case, TPE was performed once daily. After TPE, the levels of triglyceride and amylase decreased from 2210 mg/dL and 1618 IU/L to 154 mg/dL and 110 IU/L, respectively. Local and systemic complications due to acute pancreatitis were not observed. Clinical signs and laboratory values improved. At the two-year follow-up of both patients, acute pancreatitis had not recurred with regular fenofibrate treatment. Hypertriglyceridemia should be considered in patients with acute recurrent pancreatitis. Although there is no definitive evidence for early application of TPE in severe hypertriglyceridemia-induced acute pancreatitis yet, therapy with TPE may be of benefit, improving the clinical course.


Asunto(s)
Hipertrigliceridemia/complicaciones , Pancreatitis/terapia , Intercambio Plasmático/métodos , Enfermedad Aguda , Adulto , Amilasas/sangre , Femenino , Humanos , Masculino , Pancreatitis/etiología , Recurrencia , Resultado del Tratamiento , Triglicéridos/sangre
8.
Turk J Gastroenterol ; 20(1): 3-8, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19330728

RESUMEN

BACKGROUND/AIMS: Many studies have reported image analysis techniques, such as nuclear morphometry, counting or calculating of mitotic figures or estimation of the ratio of positive-stained areas immunohistochemically. The esophagus is the most commonly involved organ during caustic ingestion, which leads to progressive and devastating results after caustic burn. The aim of this work was to compare the classical stenosis index method with a new objective method based on image analysis that was used to determine experimental stricture of the rat esophagus. METHODS: We investigated this technique by randomly allocating 20 rats each to sham laparotomy and corrosive esophagitis groups. The images of the sham laparotomy group and corrosive esophagitis group were reviewed, analyzed and used in a mathematical operation on the computer. The numbers and the ratio of luminal area and total esophageal area were used to determine the esophageal stricture of the rat, and results were compared with stenosis index ratios. RESULTS: The mean area of the lumen of the esophagus and the ratio of esophageal lumen/total esophageal area were 0.83 (0.51-1.28) mm2 and 0.21 (0.08-0.37), respectively, in the corrosive esophagitis group. In the sham laparotomy group, these values were 1.28 (0.47-3.03) mm2 and 0.26 (0.13-0.92), respectively. The differences between the two groups in luminal area and ratio of esophageal lumen/total esophageal area were statistically significant (p<0.05). CONCLUSIONS: This new technique based on image analysis seems more objective and reproducible than the classical, manual method. It is concluded that the use of this new technique dramatically reduced the subjectivity of the measurement process.


Asunto(s)
Quemaduras Químicas/patología , Estenosis Esofágica/patología , Esofagitis/patología , Procesamiento de Imagen Asistido por Computador , Patología Clínica , Animales , Cáusticos , Modelos Animales de Enfermedad , Laparotomía , Masculino , Ratas , Ratas Wistar , Hidróxido de Sodio
9.
Eur J Radiol ; 71(3): 513-8, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18597964

RESUMEN

OBJECTIVE: We compared the accuracy and tolerability of intravenous contrast enhanced spiral computed tomography colonography (CTC) and optical colonoscopy (OC) for the detection of colorectal neoplasia in symptomatic patients for colorectal neoplasia. METHODS: A prospective study was performed in 48 patients with symptomatic patients with increased risk for colorectal cancer. Spiral CTC was performed in supine and prone positions after colonic cleansing. The axial, 2D MPR and virtual endoluminal views were analyzed. Results of spiral CTC were compared with OC which was done within 15 days. The psychometric tolerance test was asked to be performed for both CTC and colonoscopy after the procedure. RESULTS: Ten lesions in 9 of 48 patients were found in CTC and confirmed with OC. Two masses and eight polyps, consisted of 1 tubulovillous, 1 tubular, 2 villous adenoma, 4 adenomatous polyp, 4 adenocarcinoma, were identified. Lesion prevalence was 21%. Sensitivity, specificity, accuracy, positive and negative predictive values were found 100%, 87%, 89%, 67% and 100%, respectively. Psychometric tolerance test showed that CTC significantly more comfortable comparing with OC (p=0.00). CTC was the preferred method in 37% while OC was preferred in 6% of patients. In both techniques, the most unpleasant part was bowel cleansing. CONCLUSION: Contrast enhanced CTC is a highly accurate method in detecting colorectal lesions. Since the technique was found to be more comfortable and less time consuming compare to OE, it may be preferable in management of symptomatic patients with increased risk for colorectal cancer.


Asunto(s)
Colonografía Tomográfica Computarizada/métodos , Colonografía Tomográfica Computarizada/psicología , Neoplasias Colorrectales/diagnóstico por imagen , Neoplasias Colorrectales/psicología , Medios de Contraste , Satisfacción del Paciente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
11.
Pediatr Surg Int ; 23(11): 1105-12, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17891406

RESUMEN

An experimental study was conducted to investigate the effects of allopurinol, which inhibits the enzyme xanthine oxidase, on oxidative stress and on the prevention of stricture development after esophageal caustic injuries in rat. A randomized controlled study was conducted and 60 Wistar albino rats were divided into 6 equal groups, three groups for the acute phase and 3 groups for the chronic phase. Caustic esophageal burn was created by application of 37.5% NaOH to the distal esophagus. Allopurinol was administered at 40 mg/kg daily. Efficacy of the treatment for the acute phase was assessed by measuring tissue malondialdehyde (MDA), nitric oxide (NO) and glutathione (GSH) at the 3rd day; and for the chronic phase by determining tissue hydroxyproline content and histopathologic damage score at the 28th day. We found an increase in XO, MDA and GSH levels and a decrease in NO levels in the acute phase. Allopurinol reinstated the increase in XO significantly, while MDA, GSH and NO levels were reinstated insignificantly. There was no significant difference in means of tissue hydroxyproline content. Histopathologic damage scores were significantly lower in the allopurinol treated group. This study, which is to our knowledge, the first in the literature investigating the influence of allopurinol on caustic esophageal burn, reveals that allopurinol effects MDA, GSH and NO levels insignificantly in the acute phase of caustic esophageal burn and decreases fibrosis significantly in the chronic phase.


Asunto(s)
Alopurinol/uso terapéutico , Quemaduras Químicas/tratamiento farmacológico , Estenosis Esofágica/tratamiento farmacológico , Esófago/lesiones , Depuradores de Radicales Libres/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Animales , Biomarcadores/metabolismo , Quemaduras Químicas/metabolismo , Cáusticos/toxicidad , Modelos Animales de Enfermedad , Estenosis Esofágica/inducido químicamente , Estenosis Esofágica/metabolismo , Esófago/metabolismo , Esófago/patología , Glutatión/metabolismo , Hidroxiprolina/metabolismo , Masculino , Malondialdehído/metabolismo , Óxido Nítrico/metabolismo , Ratas , Ratas Wistar , Espectrofotometría , Resultado del Tratamiento , Xantina Oxidasa/metabolismo
12.
Hepatogastroenterology ; 54(77): 1438-42, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17708272

RESUMEN

BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) have an increased risk for thromboembolic complications. We investigated the incidence of factor V Leiden G1691A, methylene tetrahydrofolate reductase (MTHFR) C677T, and prothrombin G20210A mutation in 27 Turkish IBD patients with no history of thromboembolic disease. METHODOLOGY: Twenty-seven patients, 22 with ulcerative colitis (UC) and 5 with Crohn's disease (CD), and 47 healthy were included to the study. The DNAs were obtained from peripheral blood by using pure polymerase chain kit. Then, factor V Leiden G1691A, which active protein C resistance positive, prothrombin G20210A and MTHFR C677T mutations were investigated in DNA by using LightCycler-Factor V Leiden G1691A mutation, Prothrombin G20210A and MTHFR C677T estimate kits. RESULTS: The heterozygote factor V Leiden G1691A mutation was detected in 3 (11.1%) patients with IBD and 2 (4.3%) controls (p > 0.05). The homozygote factor V Leiden G1691A mutation was not estimated among patients and controls. Heterozygote prothrombin G20210A mutation was detected in 2 (7.4%) patients with IBD and in 0 (0%) controls (p > 0.05). There was no homozygote prothrombin G20210A mutation in IBD and controls. Heterozygote MTHFR C677T mutation was 10 of 27 (37%) patients with IBD while 15 of 47 (32%) controls (p > 0.05). Homozygote MTHFR C677T mutation was detected in 4 patients (14.9%) with IBD and 3 (6.3%) controls (p > 0.05). CONCLUSIONS: Our study did not reveal any association between IBD and the most common hereditary thrombophilic factors and these mutations interfere with neither disease manifestations nor the thrombotic complications.


Asunto(s)
Factor V/genética , Enfermedades Inflamatorias del Intestino/genética , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Mutación , Protrombina/genética , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Turquía
13.
Dig Dis Sci ; 51(12): 2306-9, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17103034

RESUMEN

Helicobacter pylori colonizes the gastric mucosa in humans and causes chronic gastritis. NF-kappaB has a key role as a mediator in mucosal inflammation. In this study, we examined the expression of NF-kappaB in the antral epithelial cells of H. pylori-infected and H. pylori-uninfected biopsies and examined these processes in relationship with grade and activity of gastritis, density of H. pylori, presence of the intestinal metaplasia, and atrophy. Fifty biopsies (35 H. pylori-positive patients and 15 H. pylori-negative controls) were studied. NF-kappaB immunohistochemical stain was performed. NF-kappaB activity in H. pylori-infected biopsies were markedly enhanced compared with uninflamed biopsies (P = 0.001). We also found positive correlation NF-kappaB expression with severity of gastritis (according to Sydney score) (P = 0.001), activity of gastritis (P = 0.046) and H. pylori load (P < 0.001), and atrophy (P = 0.004). We did not find a significant relationship between NF-kappaB and the presence of intestinal metaplasia (P = 0.355). These findings suggested that expression of NF-kappaB has an important role in H. pylori gastritis.


Asunto(s)
Gastritis/microbiología , Infecciones por Helicobacter/metabolismo , Helicobacter pylori , FN-kappa B/metabolismo , Atrofia/patología , Biopsia , Células Epiteliales/metabolismo , Células Epiteliales/microbiología , Células Epiteliales/patología , Mucosa Gástrica/metabolismo , Mucosa Gástrica/microbiología , Mucosa Gástrica/patología , Gastritis/metabolismo , Gastritis/patología , Regulación Bacteriana de la Expresión Génica , Infecciones por Helicobacter/genética , Infecciones por Helicobacter/patología , Humanos , Metaplasia/patología , FN-kappa B/genética , Estudios Retrospectivos , Índice de Severidad de la Enfermedad
14.
World J Gastroenterol ; 12(26): 4267-9, 2006 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-16830392

RESUMEN

Type I gastric carcinoid tumors result from hypergastrinemia in 1%-7% of patients with pernicious anemia. We diagnosed pernicious anemia in a 48-year-old female patient with complaint of fatigue for three months. She had no gastrointestinal symptoms. Endoscopic examination ot the upper gastrointestinal tract revealed atrophic gastritis and a polypoid lesion in the corpus of 3-4 mm in size. Endoscopic polypectomy was performed. Histopathological examination of the specimen revealed positive chromogranin A and synaptophysin stainings compatible with the diagnosis of a carcinoid tumor. Serum gastrin level was increased, urinary 5-hydroxyindoleacetic acid was within the normal range. There was no other symptom, sign, or laboratory finding of a carcinoid syndrome in the patient. No metastasis was found with indium-111 octreotide scan, computed tomographies of abdomen and thorax. Type I gastric carcinoid tumors are only rarely solitary and patients with tumors < 1 cm in size may benefit from endoscopic polypectomy.


Asunto(s)
Anemia Perniciosa/complicaciones , Tumor Carcinoide/cirugía , Endoscopía/métodos , Pólipos/cirugía , Neoplasias Gástricas/cirugía , Tumor Carcinoide/etiología , Femenino , Gastrinas/sangre , Humanos , Persona de Mediana Edad , Neoplasias Gástricas/etiología
15.
Pediatr Surg Int ; 22(4): 363-8, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16465540

RESUMEN

AIM: An experimental study was performed to investigate the efficacy of colchicine in the prevention of fibrosis in the alkaline burn of the esophagus in rats. METHOD: A standard esophageal alkaline burn was produced by the application of 37.5% NaOH for a period of 90 s to the distal esophagus followed by a water rinse. The experiments were conducted twice with two different dosages of colchicine. In the first experiment, colchicine 1 mg/kg (i.p.) was applied once, on the first day. Group A (n:8), the sham laparotomy group; group B (n:8), the untreated group (positive control group); Group C (n:16), where the standard esophageal burn was induced and colchicine applied at a dose of 1 mg/kg i.p. in 1 ml volume, and group D (n:14), where the rats did not have any operation, but were treated with colchicine (1 mg/kg, i.p.) as in group C. In the second experiment, colchicine was applied at repeated doses of 100 microg/kg (i.p.) on the first, 7th, 14th, and 21st days. Twenty-five rats were divided into groups. Group AA (n:8), the sham laparotomy group; group BB (n:9), the untreated group (positive control group); and group CC (n:8), where the standard esophageal burn was induced and colchicine was applied at repeated doses. All the rats were killed on the 28th day and evaluated for esophageal tissue hydroxyproline content and histopathologic damage score. RESULTS: Colchicine treatment at a dose of 1 mg/kg significantly reduced the quantity of hydroxyproline in the esophageal tissue in groups C and D compared with the positive control group B (P < 0.05). However, it is associated with a mortality rate of 60%. Colchicine at repeated doses of 100 microg/kg showed no significant effect in group CC compared to the untreated group BB and in the quantity tissue of hydroxyproline content (P > 0.05). CONCLUSION: At non-toxic doses, colchicine was not effective in the treatment of alkaline esophageal burn in rats. Colchicine-like molecules with less adverse effects or colchicine itself in titrated doses may be hopeful in preventing the development of fibrosis in the alkaline burns of the esophagus.


Asunto(s)
Quemaduras Químicas/tratamiento farmacológico , Cáusticos/toxicidad , Colchicina/uso terapéutico , Esófago/patología , Sustancias Protectoras/uso terapéutico , Hidróxido de Sodio/toxicidad , Análisis de Varianza , Animales , Cáusticos/administración & dosificación , Colchicina/efectos adversos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Esófago/efectos de los fármacos , Esófago/metabolismo , Fibrosis/prevención & control , Hidroxiprolina/efectos de los fármacos , Hidroxiprolina/metabolismo , Sustancias Protectoras/efectos adversos , Ratas , Ratas Wistar , Hidróxido de Sodio/administración & dosificación , Resultado del Tratamiento , Cicatrización de Heridas/efectos de los fármacos
16.
Hepatogastroenterology ; 52(65): 1456-8, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16201095

RESUMEN

BACKGROUND/AIMS: There are few detailed reports on gastrointestinal system bleeding in Turkey. The aim of this study is to analyze the characteristics of the patients with upper gastrointestinal system bleeding who were hospitalized in our clinic. METHODOLOGY: The patients who were hospitalized in Dicle University Hospital Department of Gastroenterology from March 1992 to June 2002 were analyzed retrospectively. RESULTS: During this period of time, 296 females (23.8%) and 946 males (76.2%), total 1242 patients were hospitalized for upper gastrointestinal system bleeding. Mean age was 47 for both sexes. Distribution of the cases was as follows: 31.6% duodenal ulcer (n: 393), 30.5% esophageal variceal bleeding (n: 379), 13.7% erosive gastritis (n: 171), 6.8% erosive duodenitis (n: 85), 4.9% gastric ulcer (n: 62), 2.8% carcinoma (n: 35), and 3.5% other causes. Peptic ulcer related bleeding was the most encountered reason (37.5%, n: 466). Four percent of the cases other than esophageal variceal bleeding underwent urgent surgical intervention. Eleven percent of the cases (n: 138) resulted in death of which 65.9% were esophageal variceal bleeding (n: 91). CONCLUSIONS: The most striking result is the very high rate of esophageal variceal bleeding. This finding is in concordance with the high prevalence of the viral hepatitis in the region.


Asunto(s)
Hemorragia Gastrointestinal/epidemiología , Várices Esofágicas y Gástricas/epidemiología , Várices Esofágicas y Gástricas/mortalidad , Femenino , Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Turquía/epidemiología
17.
J Pediatr Surg ; 40(3): 505-9, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15793726

RESUMEN

PURPOSE: The aim of this study was to investigate the efficacy of trimetazidine (TMZ), an antioxidant agent, on the prevention of stricture development after esophageal caustic injuries in rat. METHODS: Thirty rats were divided into 3 equal groups. A standard esophageal caustic burn was produced by application of 37.5% NaOH for a period of 90 seconds followed by water rinse. Group A (sham) animals were uninjured. Group B rats were injured but untreated. Group C rats were injured and received TMZ (5 mg/kg/d) via intraperitoneal route. Efficacy of the treatment was assessed in 28 days by measuring stenosis index and histopathologic damage score and by determining tissue hydroxyproline content. RESULTS: The stenosis index in the TMZ-treated group was significantly lower than the untreated group, similarly in the sham laparotomy group (stenosis index: 0.34 +/- 0.10, 0.94 +/- 0.21, 0.38 +/- 0.05, respectively; P < .05). The hydroxyproline level (microgram per milligram of wet tissue) was significantly lower in the TMZ-treated group compared with untreated group, similarly in the sham laparotomy group (1.06 +/- 0.14, 1.33 +/- 0.08, 0.68 +/- 0.15 microg/mg wet tissue, respectively; P < .05). In the untreated group, histopathologic damage score was significantly higher than TMZ-treated group (P < .05). CONCLUSIONS: Trimetazidine reduces the degree of fibrosis and ameliorates histopathologic damage in experimental model of corrosive esophagitis in rats.


Asunto(s)
Quemaduras Químicas/tratamiento farmacológico , Cáusticos/toxicidad , Estenosis Esofágica/tratamiento farmacológico , Hidróxido de Sodio/toxicidad , Trimetazidina/uso terapéutico , Animales , Quemaduras Químicas/patología , Evaluación Preclínica de Medicamentos , Estenosis Esofágica/inducido químicamente , Estenosis Esofágica/patología , Esófago/química , Esófago/patología , Fibrosis , Hidroxiprolina/análisis , Inyecciones Intraperitoneales , Distribución Aleatoria , Ratas , Ratas Wistar , Trimetazidina/administración & dosificación
18.
Hepatogastroenterology ; 51(60): 1732-5, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15532815

RESUMEN

BACKGROUND/AIMS: The study is designed to identify the optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia. METHODOLOGY: Ninety-two patients were included in the study, gastric biopsies were obtained from 5 different sites: lesser curvature of the mid-antrum (A1), greater curvature of the mid-antrum (A2), incisura angularis (IA), lesser curvature of the mid-corpus (B1), greater curvature of the mid-corpus (B2). Helicobacter pylori was evaluated in sections stained with toluidine blue, and histopathological examination was performed in sections stained with hematoxylin-eosin. RESULTS: Seventy-three patients were positive for Helicobacter pylori at least in one biopsy site. Helicobacter pylori was positive in 47 patients (64.3%) in A1, in 54 patients (73.9%) in A2, in 60 patients (82.1%) in IA, 44 patients (60.2%) in B1, and in 42 patients (57.5%) in B2. The highest positivity determined was in the combination of A2 and IA sites (95.8%). Gastric atrophy was determined in 35 of 73 patients (27.1% in A1, 20% in A2, 25.7% in IA, 20% in B1, and 7% in B2). Intestinal metaplasia was determined in 31 of the Helicobacter pylori-positive patients (18% in A1, 16% in A2, 30.9% in IA, 21.8% in B1, 12.7% in B2). CONCLUSIONS: It is considered that taking biopsies from both A1 and IA sites has the highest sensitivity in detecting Helicobacter pylori. However, it is difficult to define a specific site for detecting gastric atrophy and intestinal metaplasia.


Asunto(s)
Transformación Celular Neoplásica/patología , Mucosa Gástrica/patología , Gastritis Atrófica/patología , Infecciones por Helicobacter/diagnóstico , Helicobacter pylori/aislamiento & purificación , Intestinos/patología , Adulto , Anciano , Biopsia con Aguja , Estudios de Cohortes , Estudios de Evaluación como Asunto , Femenino , Mucosa Gástrica/microbiología , Gastritis Atrófica/microbiología , Humanos , Inmunohistoquímica , Masculino , Metaplasia/patología , Persona de Mediana Edad , Medición de Riesgo , Sensibilidad y Especificidad
19.
Saudi Med J ; 25(10): 1486-8, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15494829

RESUMEN

Coincidence of salmonellosis and ulcerative colitis is a rare clinical problem. Salmonella infection was reported to complicate the ulcerative colitis, as either facilitating its occurrence or activation. In this article, we present a case with salmonellosis whose clinicopathological findings also suggested ulcerative colitis. The patient improved rapidly after taking additional mesalazine to norfloxacin treatment. We conclude that salmonella infection might have either been coincidentally present or might have triggered an early ulcerative colitis in this patient who did not have history of inflammatory bowel diseases. In case of persistent severe diarrhea despite appropriate treatment, the possibility of a coincident inflammatory bowel disease such as ulcerative colitis should always be considered, especially in endemic regions for salmonellosis.


Asunto(s)
Colitis Ulcerosa/complicaciones , Colitis Ulcerosa/diagnóstico , Infecciones por Salmonella/complicaciones , Infecciones por Salmonella/diagnóstico , Salmonella enteritidis/aislamiento & purificación , Abdomen Agudo/diagnóstico , Abdomen Agudo/etiología , Adulto , Biopsia con Aguja , Colitis Ulcerosa/tratamiento farmacológico , Colonoscopía , Quimioterapia Combinada , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Mucosa Intestinal/patología , Masculino , Mesalamina/uso terapéutico , Norfloxacino/uso terapéutico , Medición de Riesgo , Infecciones por Salmonella/tratamiento farmacológico , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
20.
Pediatr Surg Int ; 20(6): 429-33, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15108014

RESUMEN

An experimental study was performed to investigate the efficacy of ketotifen, which is a mast cell stabilizer and histamine H(1)-receptor antagonist, on the prevention of stricture development after esophageal caustic injuries in the rat. Caustic esophageal burn was created by applying 37.5% NaOH to the distal esophagus. Forty rats were divided into four equal groups. Group A (sham) animals were uninjured. Group B rats were injured but untreated. Group C rats were injured and received ketotifen (1 mg/kg/day) via the oral route. Group D rats were injured and received ketotifen (1 mg/kg/day) via the intraperitoneal route. Efficacy of the treatment was assessed on day 28 by measuring the stenosis index and histopathologic damage score and biochemically by determining tissue hydroxyproline content. The stenosis index in group B (0.93+/-0.22) was significantly increased compared with group A (0.39+/-0.06, p <0.05), group C (0.42+/-0.09, p <0.05), and group D (0.35+/-0.07, p <0.05). The hydroxyproline level ( micro g/mg wet tissue) was significantly increased in group B (1.31+/-0.08, p <0.05) compared with group A (0.69+/-0.16, p <0.05), group C (1.06+/-0.16, p <0.05), and group D (0.95+/-0.12, p <0.05). In group B the histopathologic damage score was significantly higher than in groups C ( p<0.05) and D ( p<0.05). There was no significant difference between group C and group D in terms of all parameters evaluated. Treatment with ketotifen decreased tissue hydroxyproline levels, histological damage, and the stenosis index. We conclude that ketotifen has a preventive effect in the development of fibrosis in an experimental model of corrosive esophagitis in rats.


Asunto(s)
Quemaduras Químicas/tratamiento farmacológico , Estenosis Esofágica/inducido químicamente , Estenosis Esofágica/tratamiento farmacológico , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Cetotifen/uso terapéutico , Animales , Quemaduras Químicas/patología , Estenosis Esofágica/patología , Esófago/patología , Fibrosis/patología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...